-
Screen smallpox vaccinees for cardiac factors; Unannounced surveys will be Joint Commissions norm; FDA warns of cancer drug misrepresentations; FDA revises warnings, recalls drug.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
Crohns disease, one major type of inflammatory bowel disease, has an incidence rate in the United States of approximately seven per 100,000. Advancing biotechnological knowledge regarding this idiopathic disease has led to the development of therapies aimed at specific targets in the disease pathway.
-
The following drugs are in various stages of clinical studies and trials.
-
-
The bar code proposal of the U.S. Food and Drug Administration isnt the only measure being lauded by the Institute for Safe Medication Practices in Huntingdon Valley, PA. The safety organization also praises two bills recently passed by the U.S. House of Representatives.
-
In a move that will encourage such programs across the nation, a federal judge has ruled in favor of a Medicaid program that uses preferred drug lists and prior authorization.
-
Research has indicated that women have risked their health by long-term use of hormone replacement therapy. Now new research says the therapy seems to have little benefit in aiding quality-of-life measures either.
-
The triptans are 5-hydroxytryptamine (5-HT) 1B/1D receptor agonists. The major use for this class of drugs is for the acute treatment of migraines with or without an aura in adults.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
